1-(D-Ribofuranosyl)-1,4-dihydro-3-pyridinecarboxamide(CAS: 19132-12-8)

CAS Number
Related Products
Other Suppliers for 1-(D-Ribofuranosyl)-1,4-dihydro-3-pyridinecarboxamide
Basic Information
Molecular Formula
C11H16N2O5
Molecular Weight
256.26 g/mol
Chemical Identifiers
SMILES
C1C=CN(C=C1C(=O)N)C2[C@@H]([C@@H]([C@H](O2)CO)O)O
InChIKey
MAKBMGXNXXXBFE-YIPHXTPMSA-N
Database References
MDL Number
MFCD12405004
FAQ
The compound 1-(D-Ribofuranosyl)-1,4-dihydro-3-pyridinecarboxamide (CAS: 19132-12-8) falls under GHS classification for hazardous chemicals, and is subject to REACH regulations in the European Union. It is also regulated by the FDA for specific applications such as pharmaceuticals or food additives. Proper handling, storage, and disposal must comply with EPA guidelines to prevent environmental contamination.
In the synthesis of related compounds, 1-(D-Ribofuranosyl)-1,4-dihydro-3-pyridinecarboxamide (CAS: 19132-12-8) can be replaced by similar structural analogs, such as other pyridine derivatives or ribonucleoside analogs. Common alternative reagents include various nucleoside monophosphates or other nucleoside derivatives, which can be used in synthetic routes to achieve similar functional groups.
The market for 1-(D-Ribofuranosyl)-1,4-dihydro-3-pyridinecarboxamide (CAS: 19132-12-8) is primarily driven by its potential applications in pharmaceuticals, particularly as an antiviral agent. Research trends include the exploration of its antiviral properties against various virus strains, as well as its role in gene therapy and nucleic acid research. Price trends are influenced by supply and demand dynamics in the pharmaceutical industry.
Waste containing 1-(D-Ribofuranosyl)-1,4-dihydro-3-pyridinecarboxamide (CAS: 19132-12-8) should be collected in a sealed container and disposed of through a professional waste disposal service. Proper incineration methods should be used to ensure complete destruction of the compound. Environmental protection measures include proper labeling of waste containers and adherence to local regulations to prevent soil and water contamination.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Wang Yongmei
maggie@mylandpharm.com
Mobile
18656033903
Telephone
0512-66706057-8005
Visit Website
https://www.mylandpharm.comAddress
China (Jiangsu) Free Trade Zone Suzhou Pilot Zone Suzhou Industrial Park Dongping Street No.262 Creative Industry Park Layer 2 Room 208

![Sodium 5'-O-[({[2-(trimethylammonio)ethoxy]phosphinato}oxy)phosphinato]cytidine](https://static.chemtradehub.com/structs/338/33818-15-4-453b.webp)

![6H-Dibenzo[b,d]pyran-6-one, 3,8-dihydroxy-](https://static.chemtradehub.com/structs/114/1143-70-0-04a0.webp)

![N~2~-(2-Methoxyphenyl)-N-(4-methoxy-3-pyridinyl)-N~2~-[(4-methylphenyl)sulfonyl]glycinamide](https://static.chemtradehub.com/structs/189/1890208-58-8-1a3e.webp)
![4-[3-(4-Hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-imidazolidinyl]-2-(trifluoromethyl)benzonitrile](https://static.chemtradehub.com/structs/154/154992-24-2-1462.webp)


![3-carbamoyl-1-[(2R,3R,4S,5R)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-1λ?-pyridin-1-ylium](https://static.chemtradehub.com/structs/109/1094-61-7-ae32.webp)
